
    
      This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in
      adults with GAD.

      Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who
      fulfill the inclusion/exclusion criteria, will be enrolled in this study.

      This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in
      adults with GAD.

      Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who
      fulfill the inclusion/exclusion criteria, will be enrolled in this study.
    
  